116 related articles for article (PubMed ID: 23152192)
1. Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease.
Ubhi K; Rockenstein E; Vazquez-Roque R; Mante M; Inglis C; Patrick C; Adame A; Fahnestock M; Doppler E; Novak P; Moessler H; Masliah E
J Neurosci Res; 2013 Feb; 91(2):167-77. PubMed ID: 23152192
[TBL] [Abstract][Full Text] [Related]
2. IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer's disease model mice.
Mellott TJ; Pender SM; Burke RM; Langley EA; Blusztajn JK
PLoS One; 2014; 9(4):e94287. PubMed ID: 24732467
[TBL] [Abstract][Full Text] [Related]
3. Differential Regulation of Neurotrophic Factors During Pathogenic Tau-Aggregation in a Tau Transgenic Mouse Model for Alzheimer's Disease: A Protocol for Double-Labeling mRNA by In Situ Hybridization and Protein Epitopes by Immunohistochemistry.
Schindowski K
Methods Mol Biol; 2024; 2754():361-385. PubMed ID: 38512677
[TBL] [Abstract][Full Text] [Related]
4. Diminished trkA receptor signaling reveals cholinergic-attentional vulnerability of aging.
Parikh V; Howe WM; Welchko RM; Naughton SX; D'Amore DE; Han DH; Deo M; Turner DL; Sarter M
Eur J Neurosci; 2013 Jan; 37(2):278-93. PubMed ID: 23228124
[TBL] [Abstract][Full Text] [Related]
5. Retinal changes in the Tg-SwDI mouse model of Alzheimer's disease.
Oliveira-Souza FG; DeRamus ML; van Groen T; Lambert AE; Bolding MS; Strang CE
Neuroscience; 2017 Jun; 354():43-53. PubMed ID: 28450267
[TBL] [Abstract][Full Text] [Related]
6. Identification of Novel Positive Allosteric Modulators of Neurotrophin Receptors for the Treatment of Cognitive Dysfunction.
Dahlström M; Madjid N; Nordvall G; Halldin MM; Vazquez-Juarez E; Lindskog M; Sandin J; Winblad B; Eriksdotter M; Forsell P
Cells; 2021 Jul; 10(8):. PubMed ID: 34440640
[TBL] [Abstract][Full Text] [Related]
7. Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer's Disease.
Kwakowsky A; Milne MR; Waldvogel HJ; Faull RL
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999310
[TBL] [Abstract][Full Text] [Related]
8. A new role for matrix metalloproteinase-3 in the NGF metabolic pathway: Proteolysis of mature NGF and sex-specific differences in the continuum of Alzheimer's pathology.
Pentz R; Iulita MF; Mikutra-Cencora M; Ducatenzeiler A; Bennett DA; Cuello AC
Neurobiol Dis; 2021 Jan; 148():105150. PubMed ID: 33130223
[TBL] [Abstract][Full Text] [Related]
9. Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice.
Capsoni S; Giannotta S; Cattaneo A
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12432-7. PubMed ID: 12205295
[TBL] [Abstract][Full Text] [Related]
10. Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction.
Wei W; Liu Y; Dai CL; Baazaoui N; Tung YC; Liu F; Iqbal K
J Alzheimers Dis; 2021; 82(2):631-646. PubMed ID: 34057082
[TBL] [Abstract][Full Text] [Related]
11. NGF-Dependent Changes in Ubiquitin Homeostasis Trigger Early Cholinergic Degeneration in Cellular and Animal AD-Model.
Latina V; Caioli S; Zona C; Ciotti MT; Borreca A; Calissano P; Amadoro G
Front Cell Neurosci; 2018; 12():487. PubMed ID: 30618634
[TBL] [Abstract][Full Text] [Related]
12. Nerve Growth Factor Pathobiology During the Progression of Alzheimer's Disease.
Mufson EJ; Counts SE; Ginsberg SD; Mahady L; Perez SE; Massa SM; Longo FM; Ikonomovic MD
Front Neurosci; 2019; 13():533. PubMed ID: 31312116
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective Effects of Nanowired Delivery of Cerebrolysin with Mesenchymal Stem Cells and Monoclonal Antibodies to Neuronal Nitric Oxide Synthase in Brain Pathology Following Alzheimer's Disease Exacerbated by Concussive Head Injury.
Sharma HS; Muresanu DF; Nozari A; Lafuente JV; Buzoianu AD; Tian ZR; Huang H; Feng L; Bryukhovetskiy I; Manzhulo I; Wiklund L; Sharma A
Adv Neurobiol; 2023; 32():139-192. PubMed ID: 37480461
[TBL] [Abstract][Full Text] [Related]
14. Investigating In Situ Expression of Neurotrophic Factors and Partner Proteins in Irreversible Pulpitis.
Israr F; Masood Ul Hasan S; Hussain M; Qazi FUR; Hasan A
J Endod; 2023 Dec; 49(12):1668-1675. PubMed ID: 37660765
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic neuron gene expression differences captured by translational profiling in a mouse model of Alzheimer's disease.
McKeever PM; Kim T; Hesketh AR; MacNair L; Miletic D; Favrin G; Oliver SG; Zhang Z; St George-Hyslop P; Robertson J
Neurobiol Aging; 2017 Sep; 57():104-119. PubMed ID: 28628896
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Cerebral Blood Volume under Normobaric Hyperoxia in the J20-hAPP Mouse Model of Alzheimer's Disease.
Shabir O; Sharp P; Rebollar MA; Boorman L; Howarth C; Wharton SB; Francis SE; Berwick J
Sci Rep; 2020 May; 10(1):7518. PubMed ID: 32371859
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of myelin deficits in the 5xFAD mouse model for Alzheimer's disease and the protective role of BDNF.
Zota I; Chanoumidou K; Charalampopoulos I; Gravanis A
Glia; 2024 Apr; 72(4):809-827. PubMed ID: 38205694
[TBL] [Abstract][Full Text] [Related]
18. Kamikihito reduces β-amyloid
Nagamatsu T; Kubota K; Watanabe T; Katsurabayashi S; Iwasaki K
J Nat Med; 2024 Jan; 78(1):246-254. PubMed ID: 38010476
[TBL] [Abstract][Full Text] [Related]
19. Phytochemicals that regulate neurodegenerative disease by targeting neurotrophins: a comprehensive review.
Venkatesan R; Ji E; Kim SY
Biomed Res Int; 2015; 2015():814068. PubMed ID: 26075266
[TBL] [Abstract][Full Text] [Related]
20. Neurotrophic Natural Products.
Fukuyama Y; Kubo M; Harada K
Prog Chem Org Nat Prod; 2024; 123():1-473. PubMed ID: 38340248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
